ASX 200
Checkout Our Recommendations for free - 7 day free trial Subscribe Now

Next Science Ltd - NXS share price

Current Price: $ - -
Updated At: -

About

Next Science Limited (ASX: NXS) is an Australia-based medical technology company. The Company's principal activities include development and commercialization of XBIO technology. The XBIO technology is a non-toxic technology used in solving the problems of bacterial biofilms. The Company's product includes XPERIENCE, SURGX, BACTISURE and BLASTX. The XPERIENCE product is an antimicrobial solution used to prevent surgical site infections by rinsing away debris and microorganisms. SURGX Sterile Antimicrobial Gel is used to reduce surgical site and post-surgical infections by destroying planktonic and biofilm-based bacteria within the gel. The BLASTX is an antimicrobial wound gel.

Company Profile

Market Cap: -
Enterprise Value: -
Shares Outstanding: -
Shares Float: -
P/E Ratio: -
PEG Ratio: -
Book Value: -
Revenue TTM: -
Div Yield: -
Earning Share: -
Dividend per Share: -
Profit Margin: -

Disclaimer: The above financial data is sourced from EODHD and is for informational purposes only. Veye does not guarantee the accuracy or completeness of this data. Investors should conduct their own research and consult with a financial advisor before making investment decisions.

Top Shareholders

Price Summary

Today's High -
Price High
Today's Low -
Price Low
52 Week High: -
Price High
52 Week Low: -
Price Low
Price High
Week's High: -
Price Low
Week's Low: -

Price Chart

Get Your FREE Report

Discover the Top ASX Stocks to Invest In 2026!

Expert Analysis of Top-Performing ASX Stocks

Market Insights and In-Depth Research

Buy, Sell, And Hold Recommendations

Almost There!

Enter your details to download the report

Success!

Preparing your download...

Latest Reports from Veye